Stock 603896 ZHEJIANG SHOUXIANGU PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

Equities

603896

CNE100002XJ4

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-06 pm EDT 		5-day change 1st Jan Change
27.46 CNY -0.36% Intraday chart for Zhejiang Shouxiangu Pharmaceutical Co., Ltd. +1.03% -14.83%
Apr. 25 Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 5,042 8,835 7,821 6,391 5,444 - -
Enterprise Value (EV) 1 5,042 8,835 7,821 6,391 5,444 5,444 5,444
P/E ratio 32.8 x 43.3 x 27.7 x 24.8 x 18.7 x 14.8 x 13.3 x
Yield - 0.7% 1.11% 1.21% 1.68% 2.04% 2.33%
Capitalization / Revenue - 11.5 x 9.43 x 8.15 x 6.18 x 5.1 x 4.86 x
EV / Revenue - 11.5 x 9.43 x 8.15 x 6.18 x 5.1 x 4.86 x
EV / EBITDA - - 22,035,983 x - - - -
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Price to Book - 5.46 x 4.3 x 3.1 x 2.32 x 2.09 x 1.87 x
Nbr of stocks (in thousands) 186,581 198,015 197,198 198,244 198,244 - -
Reference price 2 27.02 44.62 39.66 32.24 27.46 27.46 27.46
Announcement Date 3/31/21 1/27/22 3/3/23 4/25/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 767.1 829.1 784.3 881 1,068 1,120
EBITDA - - 354.9 - - - -
EBIT 1 - 207.2 280.9 254.7 303 378.5 424
Operating Margin - 27% 33.88% 32.48% 34.39% 35.44% 37.86%
Earnings before Tax (EBT) 1 - 201.1 278 254.9 297 374 418
Net income 1 151.5 200.8 277.8 254.5 296 374 417
Net margin - 26.18% 33.51% 32.44% 33.6% 35.02% 37.23%
EPS 2 0.8231 1.031 1.430 1.300 1.470 1.855 2.070
Free Cash Flow - - - - - - -
FCF margin - - - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share 2 - 0.3115 0.4400 0.3900 0.4600 0.5600 0.6400
Announcement Date 3/31/21 1/27/22 3/3/23 4/25/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - - - - - -
ROE (net income / shareholders' equity) - 13.5% 16.1% 12.4% 12.4% 14.5% 14.1%
ROA (Net income/ Total Assets) - - 9.73% - 9.6% 10.6% 11.2%
Assets 1 - - 2,856 - 3,083 3,528 3,723
Book Value Per Share 2 - 8.170 9.210 10.40 11.80 13.10 14.70
Cash Flow per Share 2 - 1.520 1.730 1.560 1.570 1.970 2.280
Capex 1 - 162 182 415 102 87 102
Capex / Sales - 21.06% 22% 52.85% 11.58% 8.15% 9.11%
Announcement Date 3/31/21 1/27/22 3/3/23 4/25/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
27.46
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
ZHEJIANG SHOUXIANGU PHARMACEUTICAL CO., LTD. Stock Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
-14.83% 758M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+43.96% 6.32B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-15.56% 4.49B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-6.52% 3.3B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+5.47% 3.19B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-0.76% 2.6B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+56.34% 2.05B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-4.11% 1.77B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+2.93% 1.7B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-8.02% 1.63B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 603896 Stock
  4. Financials Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW